Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 113 Pages
Report ld: 3482194
Request Sample
Customized Report
Allergy Diagnostics and Testing Market Size(US$)

CAGR 2025-2031
8.4%
Market Size,2031
USD 2,519
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Allergy Diagnostics and Testing was estimated to be worth US$ 1443 million in 2024 and is forecast to a readjusted size of US$ 2519 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
The Allergy Diagnostics Reagent market is driven by the increasing prevalence of allergic disorders and the growing demand for accurate and early diagnosis. Allergies have become a global health concern, affecting a significant portion of the population, and there is a rising awareness about the importance of identifying allergens to manage symptoms effectively. The development of advanced allergy diagnostics reagents, including allergen extracts, specific IgE tests, and molecular assays, has improved the accuracy and specificity of allergy testing, contributing to market growth. Moreover, the adoption of personalized medicine approaches and the emphasis on targeted treatments align with the need for precise allergy diagnosis to tailor therapies for individual patients. However, the market also faces challenges, including the diversity of allergens and the complexity of immune responses, making accurate diagnosis complex. Additionally, addressing regulatory approvals, standardization of testing procedures, and reimbursement issues pose obstacles for manufacturers and healthcare providers. To succeed, stakeholders must focus on continuous innovation in reagent development, expanding the range of detectable allergens, and collaborating with healthcare systems to ensure accurate and accessible allergy diagnostics for patients. Addressing challenges while providing reliable and comprehensive allergy testing solutions will drive market growth and contribute to better allergy management and patient outcomes.
This report aims to provide a comprehensive presentation of the global market for Allergy Diagnostics and Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Allergy Diagnostics and Testing by region & country, by Type, and by Application.
The Allergy Diagnostics and Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Diagnostics and Testing.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Allergy Diagnostics and Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Allergy Diagnostics and Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Allergy Diagnostics and Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Allergy Diagnostics and Testing Product Introduction
1.2 Global Allergy Diagnostics and Testing Market Size Forecast (2020-2031)
1.3 Allergy Diagnostics and Testing Market Trends & Drivers
1.3.1 Allergy Diagnostics and Testing Industry Trends
1.3.2 Allergy Diagnostics and Testing Market Drivers & Opportunity
1.3.3 Allergy Diagnostics and Testing Market Challenges
1.3.4 Allergy Diagnostics and Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Allergy Diagnostics and Testing Players Revenue Ranking (2024)
2.2 Global Allergy Diagnostics and Testing Revenue by Company (2020-2025)
2.3 Key Companies Allergy Diagnostics and Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Allergy Diagnostics and Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Allergy Diagnostics and Testing
2.6 Allergy Diagnostics and Testing Market Competitive Analysis
2.6.1 Allergy Diagnostics and Testing Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Allergy Diagnostics and Testing Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Diagnostics and Testing as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Inhaled Allergens
3.1.2 Food Allergens
3.1.3 Drug Allergens
3.1.4 Other Allergens
3.2 Global Allergy Diagnostics and Testing Sales Value by Type
3.2.1 Global Allergy Diagnostics and Testing Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Allergy Diagnostics and Testing Sales Value, by Type (2020-2031)
3.2.3 Global Allergy Diagnostics and Testing Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostic Laboratories
4.1.2 Hospital-based Laboratories
4.1.3 Other
4.2 Global Allergy Diagnostics and Testing Sales Value by Application
4.2.1 Global Allergy Diagnostics and Testing Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Allergy Diagnostics and Testing Sales Value, by Application (2020-2031)
4.2.3 Global Allergy Diagnostics and Testing Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Allergy Diagnostics and Testing Sales Value by Region
5.1.1 Global Allergy Diagnostics and Testing Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Allergy Diagnostics and Testing Sales Value by Region (2020-2025)
5.1.3 Global Allergy Diagnostics and Testing Sales Value by Region (2026-2031)
5.1.4 Global Allergy Diagnostics and Testing Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Allergy Diagnostics and Testing Sales Value, 2020-2031
5.2.2 North America Allergy Diagnostics and Testing Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Allergy Diagnostics and Testing Sales Value, 2020-2031
5.3.2 Europe Allergy Diagnostics and Testing Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Allergy Diagnostics and Testing Sales Value, 2020-2031
5.4.2 Asia Pacific Allergy Diagnostics and Testing Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Allergy Diagnostics and Testing Sales Value, 2020-2031
5.5.2 South America Allergy Diagnostics and Testing Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Allergy Diagnostics and Testing Sales Value, 2020-2031
5.6.2 Middle East & Africa Allergy Diagnostics and Testing Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Allergy Diagnostics and Testing Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Allergy Diagnostics and Testing Sales Value, 2020-2031
6.3 United States
6.3.1 United States Allergy Diagnostics and Testing Sales Value, 2020-2031
6.3.2 United States Allergy Diagnostics and Testing Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Allergy Diagnostics and Testing Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Allergy Diagnostics and Testing Sales Value, 2020-2031
6.4.2 Europe Allergy Diagnostics and Testing Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Allergy Diagnostics and Testing Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Allergy Diagnostics and Testing Sales Value, 2020-2031
6.5.2 China Allergy Diagnostics and Testing Sales Value by Type (%), 2024 VS 2031
6.5.3 China Allergy Diagnostics and Testing Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Allergy Diagnostics and Testing Sales Value, 2020-2031
6.6.2 Japan Allergy Diagnostics and Testing Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Allergy Diagnostics and Testing Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Allergy Diagnostics and Testing Sales Value, 2020-2031
6.7.2 South Korea Allergy Diagnostics and Testing Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Allergy Diagnostics and Testing Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Allergy Diagnostics and Testing Sales Value, 2020-2031
6.8.2 Southeast Asia Allergy Diagnostics and Testing Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Allergy Diagnostics and Testing Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Allergy Diagnostics and Testing Sales Value, 2020-2031
6.9.2 India Allergy Diagnostics and Testing Sales Value by Type (%), 2024 VS 2031
6.9.3 India Allergy Diagnostics and Testing Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Allergy Diagnostics and Testing Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 BioMerieux
7.2.1 BioMerieux Profile
7.2.2 BioMerieux Main Business
7.2.3 BioMerieux Allergy Diagnostics and Testing Products, Services and Solutions
7.2.4 BioMerieux Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.2.5 BioMerieux Recent Developments
7.3 Minaris Medical America
7.3.1 Minaris Medical America Profile
7.3.2 Minaris Medical America Main Business
7.3.3 Minaris Medical America Allergy Diagnostics and Testing Products, Services and Solutions
7.3.4 Minaris Medical America Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.3.5 Minaris Medical America Recent Developments
7.4 PerkinElmer
7.4.1 PerkinElmer Profile
7.4.2 PerkinElmer Main Business
7.4.3 PerkinElmer Allergy Diagnostics and Testing Products, Services and Solutions
7.4.4 PerkinElmer Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.4.5 PerkinElmer Recent Developments
7.5 HAL Allergy Group
7.5.1 HAL Allergy Group Profile
7.5.2 HAL Allergy Group Main Business
7.5.3 HAL Allergy Group Allergy Diagnostics and Testing Products, Services and Solutions
7.5.4 HAL Allergy Group Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.5.5 HAL Allergy Group Recent Developments
7.6 Siemens Healthineers
7.6.1 Siemens Healthineers Profile
7.6.2 Siemens Healthineers Main Business
7.6.3 Siemens Healthineers Allergy Diagnostics and Testing Products, Services and Solutions
7.6.4 Siemens Healthineers Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.6.5 Siemens Healthineers Recent Developments
7.7 Stallergenes Greer
7.7.1 Stallergenes Greer Profile
7.7.2 Stallergenes Greer Main Business
7.7.3 Stallergenes Greer Allergy Diagnostics and Testing Products, Services and Solutions
7.7.4 Stallergenes Greer Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.7.5 Stallergenes Greer Recent Developments
7.8 HOB Biotech Group
7.8.1 HOB Biotech Group Profile
7.8.2 HOB Biotech Group Main Business
7.8.3 HOB Biotech Group Allergy Diagnostics and Testing Products, Services and Solutions
7.8.4 HOB Biotech Group Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.8.5 HOB Biotech Group Recent Developments
7.9 Lincoln Diagnostics
7.9.1 Lincoln Diagnostics Profile
7.9.2 Lincoln Diagnostics Main Business
7.9.3 Lincoln Diagnostics Allergy Diagnostics and Testing Products, Services and Solutions
7.9.4 Lincoln Diagnostics Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.9.5 Lincoln Diagnostics Recent Developments
7.10 MEDIWISS Analytic
7.10.1 MEDIWISS Analytic Profile
7.10.2 MEDIWISS Analytic Main Business
7.10.3 MEDIWISS Analytic Allergy Diagnostics and Testing Products, Services and Solutions
7.10.4 MEDIWISS Analytic Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.10.5 MEDIWISS Analytic Recent Developments
7.11 Danaher
7.11.1 Danaher Profile
7.11.2 Danaher Main Business
7.11.3 Danaher Allergy Diagnostics and Testing Products, Services and Solutions
7.11.4 Danaher Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.11.5 Danaher Recent Developments
7.12 Hycor Biomedical
7.12.1 Hycor Biomedical Profile
7.12.2 Hycor Biomedical Main Business
7.12.3 Hycor Biomedical Allergy Diagnostics and Testing Products, Services and Solutions
7.12.4 Hycor Biomedical Allergy Diagnostics and Testing Revenue (US$ Million) & (2020-2025)
7.12.5 Hycor Biomedical Recent Developments
8 Industry Chain Analysis
8.1 Allergy Diagnostics and Testing Industrial Chain
8.2 Allergy Diagnostics and Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Allergy Diagnostics and Testing Sales Model
8.5.2 Sales Channel
8.5.3 Allergy Diagnostics and Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Allergy Diagnostics and Testing was estimated to be worth US$ 1553 million in 2025 and is projected to reach US$ 2709 million, growing at a CAGR of 8.4% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 120
USD 3950.00
(Single User License)
The global Allergy Diagnostics and Testing market was valued at US$ 1553 million in 2025 and is anticipated to reach US$ 2709 million by 2032, at a CAGR of 8.4% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 111
USD 2900.00
(Single User License)
The global Allergy Diagnostics and Testing market size was US$ 1443 million in 2024 and is forecast to a readjusted size of US$ 2519 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 97
USD 4250.00
(Single User License)
The global Allergy Diagnostics and Testing market is projected to grow from US$ 1443 million in 2024 to US$ 2519 million by 2031, at a CAGR of 8.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 142
USD 4900.00
(Single User License)
The global market for Allergy Diagnostics and Testing was valued at US$ 1443 million in the year 2024 and is projected to reach a revised size of US$ 2519 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Published Date: 2025-01-16
Pages: 85
USD 2900.00
(Single User License)
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published Date: 2024-04-12
Pages: 112
USD 4900.00
(Single User License)
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published Date: 2024-01-12
Pages: 88
USD 2900.00
(Single User License)
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published Date: 2024-01-08
Pages: 109
USD 3950.00
(Single User License)
The global market for Allergy Diagnostics and Testing was estimated to be worth US$ 1553 million in 2025 and is projected to reach US$ 2709 million, growing at a CAGR of 8.4% from 2026 to 2032.
Published: 2026-06-16
Pages: 120
The global Allergy Diagnostics and Testing market was valued at US$ 1553 million in 2025 and is anticipated to reach US$ 2709 million by 2032, at a CAGR of 8.4% from 2026 to 2032.
Published: 2026-04-17
Pages: 111
The global Allergy Diagnostics and Testing market size was US$ 1443 million in 2024 and is forecast to a readjusted size of US$ 2519 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 97
The global Allergy Diagnostics and Testing market is projected to grow from US$ 1443 million in 2024 to US$ 2519 million by 2031, at a CAGR of 8.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 142
The global market for Allergy Diagnostics and Testing was valued at US$ 1443 million in the year 2024 and is projected to reach a revised size of US$ 2519 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Published: 2025-01-16
Pages: 85
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published: 2024-04-12
Pages: 112
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published: 2024-01-12
Pages: 88
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
Published: 2024-01-08
Pages: 109
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now